The macro setup
Two conditions are squeezing the middle of the income statement at small hardware and manufacturing companies this year.
The first is component cost inflation and supply chain disruption. Ceragon Networks named both explicitly when it cut its full-year non-GAAP gross margin guidance on August 11, 2026 while leaving its revenue guidance untouched: management expects to sell what it said it would sell, and to keep less of it. Aviat Networks attributed a 560 basis point gross margin decline to regional and product mix in its fiscal third quarter released May 4, 2026.
The second is the cost of buying growth. A small manufacturer scaling into a new geography or a new customer typically prices to win, absorbs ramp inefficiency, and reports the revenue before it reports the margin. That is a legitimate strategy. It is also indistinguishable, in a single quarter's headline, from a business with no pricing power at all.
Against that, the third quarter of 2026 has produced a smaller group moving decisively the other way, expanding margin while growing revenue. What separates the two groups is not sector. It is whether the company sells a product a customer cannot easily source elsewhere.
Why microcaps specifically
Where small companies are structurally exposed. A microcap manufacturer buys components in volumes that command no priority and no price protection. When a supplier allocates, the small customer is allocated last and priced worst. It also sells into concentrated customer bases, often a handful of buyers, each large enough to dictate terms. The result is a business that absorbs cost increases at the input end and cannot pass them on at the output end. That is the entire mechanism, and it appears on exactly one line of the income statement.
Scale of the effect matters too. At a company with $60 million of quarterly revenue, a 500 basis point margin decline removes $3 million of gross profit. If that company's entire quarterly operating expense base is $12 million, it has just lost a quarter of the cushion between operations and a loss.
Where small companies have an edge. Specialization. A company making one narrow product that a large competitor considers immaterial can hold pricing indefinitely, because there is nobody willing to compete the margin away for a market that small. Regulatory position works the same way: a classification, certification or compliance status that competitors lack functions as a price floor. Software and services mix does too, since neither carries component cost.
Both halves are real, and the same company can sit on both sides in different product lines.
The landscape
The companies below are illustrative of the range. They are not endorsements, not recommendations, and not a screened watchlist. Each figure is drawn from the company's own most recent reported results, dated in each line.
Margin expanding:
- Wrap Technologies (NASDAQ: WRAP). Per second quarter results released August 11, 2026, revenue rose 103% to $2.1 million while gross margin expanded to approximately 75% from 48%. Across the first six months, revenue rose 78% to $3.2 million and gross margin reached approximately 71% against approximately 61%. Gross profit grew faster than revenue, and net loss narrowed 39% to $2.3 million. Cash was $4.8 million at June 30, 2026.
Margin compressing:
- CBAK Energy Technology (NASDAQ: CBAT). Per fourth quarter 2025 results released March 30, 2026, revenue rose to $58.8 million from $25.37 million while gross margin fell to 7.3% from 13.1%. Revenue more than doubled; gross profit rose roughly 29%, from $3.31 million to $4.28 million. Trailing twelve month revenue is $229.87 million against a net loss of $17.09 million.
- Ceragon Networks (NASDAQ: CRNT). Per second quarter results reported August 11, 2026, revenue rose 14.2% to $93.9 million while GAAP gross margin fell to 31.7% from 34.6%. GAAP operating income fell to $0.2 million from $2.2 million. Full-year revenue guidance of $355 million to $385 million was maintained; non-GAAP gross margin guidance was cut to 33.5% to 34.5%.
- Aviat Networks (NASDAQ: AVNW). Per fiscal third quarter results released May 4, 2026, GAAP gross margin fell to 29.3% from 34.9%, a decline of 560 basis points, on revenue of $100.0 million that was itself down 11.22% year over year. Falling revenue and falling margin together is the harder combination.
Growing through the pressure:
- Silicom (NASDAQ: SILC). Per second quarter results released July 29, 2026, revenue rose 59% to $23.8 million from $15.0 million, and full-year guidance was raised to $93 million to $95 million, up roughly 50%. Non-GAAP earnings per share nonetheless fell to $0.16 from $0.35, and trailing net income was negative $9.79 million. Revenue up 59%, per-share non-GAAP earnings down: the growth is real and it has not yet reached the bottom line.
- One Stop Systems (NASDAQ: OSS). Per second quarter results released August 5, 2026, revenue rose 62.3% to $9.35 million with record bookings of $15.1 million, while gross margin fell to 39.1% from 41.3%. GAAP net loss from continuing operations widened to $7.3 million from $2.5 million.
Read the two lists together. Every company here reported growth. The one expanding margin did so on a regulatory classification and a product mix shift, not on volume. The ones compressing margin are, without exception, the ones adding volume fastest.
Risks unique to microcaps here
- The headline and the economics can point opposite ways. CBAK announced an order worth approximately $96 million on August 25, 2026, against a market capitalization of $76.55 million at the August 27 close. At the company's most recently reported 7.3% gross margin, that order carries roughly $7 million of gross profit before any operating cost. Both figures are true. Only one was in the release.
- Non-GAAP presentation widens as margin narrows. When the GAAP result deteriorates, the adjusted result carries more of the message. Aviat reported a GAAP diluted loss of $0.16 alongside non-GAAP diluted earnings of $0.06. Ceragon reported a GAAP net loss of $2.1 million alongside non-GAAP net income of $1.7 million. Neither is improper. Both require the reconciliation to interpret.
- Guidance is often split. Ceragon held revenue guidance and cut margin guidance in the same release. A reader tracking only the top line would have recorded no change at all.
- Margin recovery is slower than margin loss. Ceragon's management pointed to gradual improvement in 2027 from product redesign, price increases and industry-wide cost adjustment. Each of those takes quarters. Cost increases arrive in one.
What would change the picture
- Component cost normalisation. The compressing group named supply chain and component costs specifically. If those ease, the same volume produces materially more gross profit with no commercial change at all.
- CBAK's second quarter results, September 1, 2026. The clearest near-term test of whether thin-margin volume growth is a ramp cost or a structural condition.
- Silicom's projected return to quarterly bottom-line profitability by the end of 2026. Management has put a date on it, which makes it checkable.
- Any of the compressing group holding revenue while margin recovers. That combination, rather than another growth quarter, is what would reprice these names.
For the mechanics behind these figures, see what gross margin is and why it matters more than revenue growth, how to calculate cash runway from a 10-Q, and what a going concern warning actually tells you.
Disclosure
This article is independent editorial content and reflects the author's opinion and analysis as of the date of publication. It is not investment advice and should not be relied on as the basis for any investment decision. MicroCap Desk and its contributors received no compensation of any kind — cash, securities, or otherwise — from any company mentioned, or from any third party, in connection with this article. The author holds no position in any security mentioned. Information is drawn from sources believed reliable but is not guaranteed accurate or complete. Microcap securities carry a high risk of loss. Do your own research. See our full Disclosure.


